Biotalys lists on Euronext Brussels


€54.6 million raised – market capitalisation of approx. €232 million

Brussels – 2 July 2021 – Euronext today congratulates the agricultural technology (AgTech) company Biotalys on its IPO on Euronext Brussels (ticker code: BTLS).

Biotalys is an AgTech company focused on addressing food protection challenges with protein-based biocontrol solutions for more sustainable and safer food. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and its headquarters are located in the vibrant biotech cluster in Ghent, Belgium. 

Biotalys was listed through the admission to trading of the 30,020,387 shares making up its equity, including 6,333,333 new shares issued under a Public Offering. 949,999 additional new shares could be issued and admitted to trading upon the possible exercise of the over-allotment option.

The admission and issue price of Biotalys’ shares was set at €7.50 per share. Market capitalisation was €232.3 million on the day of listing and the offering raised €54.6 million altogether (assuming the exercise in full of the over-allotment option).

Biotalys intends to use the proceeds of the transaction to fund the development of its existing pipeline, to fund the continued improvement and optimisation of its AGROBODY Foundry™ platform, to fund its go-to-market strategy and for general corporate purposes.

Patrice Sellès, Chief Executive Officer of Biotalys, said: “Our IPO today represents years of hard work from across our company, from the Biotalys team to our investors and partners. We are proud to be listing on Euronext Brussels and entering this exciting new stage of growth as a public company. We have seen tremendous support and positive feedback for our story from international institutional and local investors alike, who – like us – believe that we can make a lasting difference to a more sustainable and safe way to protect food, reduce food waste and provide healthier and safer choices for all.


Caption: Patrice Sellès, Chief Executive Officer of Biotalys, and his team rang the bell during a ceremony this morning together with Vincent Van Dessel, CEO of Euronext Brussels, to celebrate the Initial Public Offering of the company.

About Biotalys Biotalys is an Agricultural Technology (AgTech) company focused on addressing food protection challenges with protein-based biocontrol solutions for more sustainable and safer food. Based on its novel AGROBODY™ technology platform, Biotalys aims to develop a strong and diverse pipeline of effective products with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and has since then gained support from renowned Belgian and international investors. The Company is based in the biotech cluster in Ghent, Belgium. More information can be found on

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With more than 1,900 listed issuers and around €6.5 trillion in market capitalisation as of end June 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter ( and LinkedIn (

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at

© 2023, Euronext N.V. - All rights reserved.